Articles Vol. 65 No. CĐ10 - Bệnh viện Thống Nhất 30/10/2024

47. OUTCOMES OF PERIPHERAL VASCULAR INTERVENTIONS IN PATIENTS WITH LOWER EXTREMITY ARTERY DISEASE

Nguyen Duy Tan1,2, Huynh Ngoc Hanh1,2, Tran Thi Tuyet Mai1,2, Dao Hong Quan1,2
1 Thong Nhat Hospital
2 Bệnh viện Thống Nhất
Corresponding author: ngocjhanhj@gmail.com
DOI: 10.52163/yhc.v65iCD10.1635
16 Views
11 Downloads
Keywords
peripheral artery disease lower extremity artery disease percutaneous transluminal angioplasty
Abstract

Objective: To determine the efficacy, short- term results of percutaneous transluminal angioplasty (PTA) in patients with symptomatic lower extremity artery disease.

Methods: From June to December 2020, the cross sectional, descriptive study was carried out on 30 patients with lower limb artery disease, treated by PTA in Cardiovascular and Thoracic Department, Thong Nhat hospital. All patients were evaluated by clinical symptoms, ankle- brachial index and lesion characteristic before and after the intervention to determine the initial success.

Results: Majority of lesions belong to TASC II C and D (79%). The artery treated with angioplasty were aortoiliac (68,4%), femeropopliteal (44,7%) and below-knee artery (42,1%). Balloon angioplasty and stent placement were in 24 patients (63%) and balloon angioplasty in 14 patients (27%). The ankle- brachial index before and after the intervention respectively 0,35 and 0.70 (p<0,001). Overall, the technical successful rate was 97%. The complications included access site hematoma (10%), limb amputation (5,4%), bleeding (1,7%).

Conclusion: PTA is a feasible and effective procedure for treatment of lower limb artery disease. However, we need to increase the sample size and more study of long-term patency of PTA should be conducted.

References
[1]
Conrad MF, Cambria RP, Stone DH, et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg. 2006;44:762–769. Google Scholar
[2]
Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Snyder SA, O'Leary EE, Ragheb AO, Zeller T; Zilver PTX Investigators. Durable Clinical Effectiveness Google Scholar
[3]
With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation. 2016 Apr 12;133(15):1472-83. Google Scholar
[4]
Đinh Huỳnh Linh, Phạm Mạnh Hùng và cộng sự, Đánh giá kết quả sớm can thiệp nội mạch điều trị bệnh động mạch chi dưới mạn tính ở Viện Tim mạch Việt Nam. Tạp chí Tim Mạch học Việt Nam, 75+76 (2016), 123-130. Google Scholar
[5]
Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771. Google Scholar
[6]
Klinkert P, Schepers A, Burger DH, et al. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37:149 –155 Google Scholar
[7]
Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005;41:423– 435; discussion 435 Google Scholar
[8]
L’Italien GJ, Cambria RP, Cutler BS, et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg. 1995;21:935–944. Google Scholar
[9]
Marie D. Gerhard-Herman, et al, 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease. J Am Coll Cardiol. 2017 Mar, 69 (11) e71-e126. Google Scholar
[10]
Martin Schillinger, et al. Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery. N Engl J Med 2006; 354:1879-1888 Google Scholar
[11]
Mohammad Ali Husainy, OUTBACK catheter for treatment of superficial femoral and iliac artery chronic total occlusion: Experience from two centers. Indian J Radiol Imaging. 2016 AprJun; 26(2): 249–253. Google Scholar
[12]
Mohammad Sherif. Angioplasty and stenting for peripheral arterial disease of the lower limbs. EJournal of cardiology practice. Apr 2018, p8 – 18. Google Scholar
[13]
National Center for Health Statistics: NHANES 1999–2002: lower extremity disease examination (LEX), MEC examination. [accessed 21 October 2010] Google Scholar
[14]
Nguyễn Lân Việt, Nghiên cứu mô hình bệnh tật ở bệnh nhân điều trị nội trú tại Viện Tim mạch Việt Nam trong thời gian 2003-2007. Tạp chí Tim mạch học Việt Nam, 2010. 52: p. 11-17. Google Scholar
[15]
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1–S75. Google Scholar
[16]
Phạm Minh Ánh, Lê Đức Tín, Trương Thế Hiệp và cộng sự (2014), Đánh giá kết quả phẫu thuật kết hợp can thiệp nội mạch trong điều trị tắc động mạch mạn tính chi dưới. Nghiên cứu Y học Y Học TP. Hồ Chí Minh, 18(2), 223-228. Google Scholar
[17]
Rutherford R B, Flanigan D P, Gupta S K. et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986;4(1):80–94. Google Scholar
[18]
Schmidt, A., et al., Retrograde recanalization technique for use after failed antegrade angioplasty in chronic femoral artery occlusions. J Endovasc Ther, 2012. 19(1): p. 23-9. Google Scholar
[19]
Victor Aboyans, Michael H. Criqui, et al. Measurement and Interpretation of the Ankle-Brachial IndexA Scientific Statement From the American Heart Association. Circulation, 16 Nov 2012, 126:2890–2909 Google Scholar